Hubei Guangji Pharmaceutical Co., Ltd.

000952

CNE0000010R5

Pharmaceuticals

End-of-day quote Shenzhen S.E. Other stock markets 06:00:00 2024-05-16 pm EDT			5-day change	1st Jan Change
6.22 ^CNY	-2.05%		-4.31%	-22.15%

Apr. 25	Hubei Guangji Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Apr. 25	Hubei Guangji Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Hubei Guangji Pharmaceutical Co., Ltd Appoints Hu Mingfeng as Director

October 11, 2016 at 12:37 pm EDT

Hubei Guangji Pharmaceutical Co., Ltd. announced at the EGM held on October 10, 2016, the shareholders approved the appointment of Hu Mingfeng as director.

Latest news about Hubei Guangji Pharmaceutical Co., Ltd.

Hubei Guangji Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 25	CI
Hubei Guangji Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 25	CI
Guangji Pharmaceutical Gets Nod to Produce Entecavir	Nov. 07	MT
Hubei Guangji Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-20	CI
Hubei Guangji Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-30	CI
Guangji Pharma to Establish Joint Innovation Laboratory With Jiangnan University	23-06-15	MT
Guangji Pharma to Borrow 281 Million Yuan From Bank to Support Acquisition Deals	23-05-17	MT
Hubei Guangji Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-27	CI
Hubei Guangji Pharmaceutical Announces Profit Distribution Proposal for 2022	23-04-20	CI
Hubei Guangji Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-19	CI
Guangji Pharma Registers Diabetes-Related Infection Drug	23-03-29	MT
Hubei Guangji Pharma to Invest 468 Million Yuan in Parkson Biotechnology Amid Bankruptcy Reorganization	23-02-08	MT
Hubei Guangji Pharma Signs 6MW Solar Power Project	22-12-15	MT
Hubei Guangji Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-27	CI
Guangji Pharmaceutical Unit to Resume Production After Three-Month Stoppage	22-10-04	MT
Hubei Guangji Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-18	CI
Hubei Guangji Pharmaceutical Jikang Medicine Co., Ltd. announced that it has received CNY 45 million in funding from Hubei Guangji Pharmaceutical Co., Ltd.	22-07-18	CI
Hubei Guangji Pharmaceutical Co., Ltd. Announces Cash Dividend on A Shares for the Year 2021, Payable on May 27, 2022	22-05-19	CI
Hubei Guangji Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-04-28	CI
Hubei Guangji Pharmaceutical Co., Ltd. Approves Cash Dividend for 2021	22-04-21	CI
Hubei Guangji Pharmaceutical Co., Ltd. Announces the Profit Distribution Proposal for the Year 2021	22-03-25	CI
Hubei Guangji Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	22-03-24	CI
Guangji Pharmaceutical Co. Ltd. announced that it has received CNY 180 million in funding from Hubei Guangji Pharmaceutical Co., Ltd.	21-12-01	CI
Hubei Guangji Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021	21-10-22	CI
Hubei Guangji Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021	21-08-18	CI

Chart Hubei Guangji Pharmaceutical Co., Ltd.

Duration

Period

Chart Hubei Guangji Pharmaceutical Co., Ltd.

More charts

Hubei Guangji Pharmaceutical Co., Ltd. is the Chinese leader of pharmaceutical ingredients production. The group's activity is organized around four product families: - vitamins: riboflavin and beta carotene; - food supplements; - fine chemistry products; - medicinal preparations.

Sector

Pharmaceuticals

Calendar

2024-05-29 - Annual General Meeting

More about the company

Income Statement Evolution

More financial data

Annual profits - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

	1st Jan change	Capi.
HUBEI GUANGJI PHARMACEUTICAL CO., LTD.	-22.15%	305M
ELI LILLY AND COMPANY	+32.09%	693B
NOVO NORDISK A/S	+29.39%	584B
JOHNSON & JOHNSON	-1.34%	372B
MERCK & CO., INC.	+20.34%	332B
ABBVIE INC.	+7.39%	294B
ASTRAZENECA PLC	+13.89%	239B
ROCHE HOLDING AG	-3.03%	211B
NOVARTIS AG	+10.02%	210B
AMGEN INC.	+8.49%	168B

Other Pharmaceuticals

Hubei Guangji Pharmaceutical Co., Ltd.

Equities

000952

CNE0000010R5

Pharmaceuticals

Hubei Guangji Pharmaceutical Co., Ltd Appoints Hu Mingfeng as Director

Latest news about Hubei Guangji Pharmaceutical Co., Ltd.

Chart Hubei Guangji Pharmaceutical Co., Ltd.

Company Profile

Income Statement Evolution

Annual profits - Rate of surprise

Sector Other Pharmaceuticals